Back to REGN
VANGUARD GROUP INC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
25
Latest value
$28K
Q4 2025
Peak value
$6.2B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $32.4M |
| Q1 2025 | $141.4M |
| Q1 2025 | $41.2M |
| Q1 2025 | $99.1M |
| Q1 2025 | $5.7B |
| Q1 2025 | $23K |
| Q2 2025 | $27.6M |
| Q2 2025 | $118.5M |
| Q2 2025 | $31.8M |
| Q2 2025 | $85.8M |
| Q2 2025 | $4.7B |
| Q2 2025 | $27K |
| Q3 2025 | $4.5B |
| Q3 2025 | $95.1M |
| Q3 2025 | $29.9M |
| Q3 2025 | $125.5M |
| Q3 2025 | $300.9M |
| Q3 2025 | $2K |
| Q3 2025 | $20K |
| Q4 2025 | $41.7M |
| Q4 2025 | $171.3M |
| Q4 2025 | $433.3M |
| Q4 2025 | $129.5M |
| Q4 2025 | $6.2B |
| Q4 2025 | $28K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $28K | 36 | — | — |
| Q4 2025 | $6.2B | 8.07M | — | — |
| Q4 2025 | $129.5M | 167.8K | — | — |
| Q4 2025 | $433.3M | 561.3K | — | — |
| Q4 2025 | $171.3M | 222.0K | — | — |
| Q4 2025 | $41.7M | 54.0K | — | — |
| Q3 2025 | $20K | 36 | — | — |
| Q3 2025 | $2K | 4 | — | — |
| Q3 2025 | $300.9M | 535.1K | — | — |
| Q3 2025 | $125.5M | 223.2K | — | — |
| Q3 2025 | $29.9M | 53.2K | — | — |
| Q3 2025 | $95.1M | 169.1K | — | — |
| Q3 2025 | $4.5B | 8.07M | — | — |
| Q2 2025 | $27K | 51 | — | — |
| Q2 2025 | $4.7B | 8.92M | — | — |
| Q2 2025 | $85.8M | 163.5K | — | — |
| Q2 2025 | $31.8M | 60.6K | — | — |
| Q2 2025 | $118.5M | 225.7K | — | — |
| Q2 2025 | $27.6M | 52.7K | — | — |
| Q1 2025 | $23K | 36 | — | — |
| Q1 2025 | $5.7B | 8.91M | — | — |
| Q1 2025 | $99.1M | 156.2K | — | — |
| Q1 2025 | $41.2M | 65.0K | — | — |
| Q1 2025 | $141.4M | 223.0K | — | — |
| Q1 2025 | $32.4M | 51.0K | — | — |
Other funds holding REGN
$5.2B
$5.1B
$4.7B
$4.3B
$3.6B
$3.6B
$3.5B
$3.4B